newsfilter
← Latest News
GlobeNewswire·

Viracta Therapeutics Announces New Employment Inducement Grant

SAN DIEGO, Sept. 19, 2022 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc. (NASDAQ:VIRX), a precision oncology company targeting virus-associated malignancies, today announced that, in connection with the appointment of Mark Rothera as Viracta's new Pres